These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 3274298)

  • 21. Different immune effects on cardiac allografts and xenografts induced by neonatal intrathymic inoculation with allogeneic and xenogeneic antigens.
    Shen Z; Pelletier S; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Heart Lung Transplant; 1996 Oct; 15(10):1034-8. PubMed ID: 8913921
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prolonged survival of a discordant cardiac xenograft in a rhesus monkey.
    Fischel RJ; Platt JL; Matas AJ; Perry E; Dalmasso AP; Manivel C; Najarian JS; Bach FH; Bolman RM
    Transplant Proc; 1991 Feb; 23(1 Pt 1):589-90. PubMed ID: 1990619
    [No Abstract]   [Full Text] [Related]  

  • 23. Cardiac xenotransplantation: recent preclinical progress with 3-month median survival.
    McGregor CG; Davies WR; Oi K; Teotia SS; Schirmer JM; Risdahl JM; Tazelaar HD; Kremers WK; Walker RC; Byrne GW; Logan JS
    J Thorac Cardiovasc Surg; 2005 Sep; 130(3):844-51. PubMed ID: 16153938
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of leflunomide in control of acute rejection in hamster-to-rat cardiac xenografts.
    Xiao F; Chong A; Foster P; Sankary H; McChesney L; Williams JM; Frieders D; Williams JW
    Transplant Proc; 1994 Jun; 26(3):1263-5. PubMed ID: 8029902
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin.
    Magee JC; Collins BH; Harland RC; Bollinger RR; Frank MM; Platt JL
    Transplant Proc; 1995 Feb; 27(1):271. PubMed ID: 7878999
    [No Abstract]   [Full Text] [Related]  

  • 26. In vivo potentiation of cyclosporine immunosuppression by calcium antagonists.
    Tesi RJ; Hong J; Butt KM; Jaffe BM; McMillen MA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1382-4. PubMed ID: 3274336
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac allotransplantation across major blood group barriers in the baboon.
    Cooper DK; Lexer G; Rose AG; Keraan M; Rees J; Du Toit E; Oriol R
    J Med Primatol; 1988; 17(6):333-46. PubMed ID: 3065510
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased immunosuppression, not anticoagulation, extends cardiac xenograft survival.
    Byrne GW; Davies WR; Oi K; Rao VP; Teotia SS; Ricci D; Tazelaar HD; Walker RC; Logan JS; McGregor CG
    Transplantation; 2006 Dec; 82(12):1787-91. PubMed ID: 17198277
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pharmacologic immunosuppression on donor heart survival in a closely related nonhuman primate xenograft model.
    Reichenspurner H; Human PA; Rose AG; Reichart B; Cooper DK
    Transplant Proc; 1990 Jun; 22(3):1086-7. PubMed ID: 2349666
    [No Abstract]   [Full Text] [Related]  

  • 30. Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts.
    Lesnikoski BA; Shaffer DA; Van der Werf WJ; Dalmasso AP; Soares MP; Latinne D; Bazin H; Hancock WW; Bach FH
    Transplant Proc; 1995 Feb; 27(1):290-1. PubMed ID: 7879007
    [No Abstract]   [Full Text] [Related]  

  • 31. FK 506 prolongs survival of liver but not heart mouse-to-rat vascularized xenografts.
    Pan F; Valdivia LA; Tsugita M; Celli S; Haeuchi K; Demetris AJ; Avci G; Fung JJ
    Transplant Proc; 1994 Jun; 26(3):1211. PubMed ID: 7518113
    [No Abstract]   [Full Text] [Related]  

  • 32. Specific intravenous carbohydrate therapy: a new approach to the inhibition of antibody-mediated rejection following ABO-incompatible allografting and discordant xenografting.
    Cooper DK; Good AH; Ye Y; Koren E; Oriol R; Ippolito RM; Malcolm AJ; Neethling FA; Romano E; Zuhdi N
    Transplant Proc; 1993 Feb; 25(1 Pt 1):377-8. PubMed ID: 8438342
    [No Abstract]   [Full Text] [Related]  

  • 33. Can cardiac allografts and xenografts be transplanted across the ABO blood group barrier?
    Cooper DK; Human PA; Rose AG; Rees J; Keraan M; DuToit E; Oriol R
    Transplant Proc; 1989 Feb; 21(1 Pt 1):549-50. PubMed ID: 2650198
    [No Abstract]   [Full Text] [Related]  

  • 34. Spectrum of vascular pathologic changes in primate cardiac xenografts.
    McManus RP; O'Hair DP; Hunter JB; Komorowski R
    Transplant Proc; 1992 Apr; 24(2):619-24. PubMed ID: 1566454
    [No Abstract]   [Full Text] [Related]  

  • 35. Rejection/acceptance of xenografts.
    Sakakibara N; Click RE; Condie RM; Jamieson SW
    Transplant Proc; 1989 Feb; 21(1 Pt 1):524-6. PubMed ID: 2650191
    [No Abstract]   [Full Text] [Related]  

  • 36. C1-Inh and heparan sulfate can prevent discordant rejection.
    Di Stefano R; Frosini F; Scavuzzo M; Ambrogi M; Fagiolini A; Ferrari M; Pelosi G; Mosca F
    Transplant Proc; 1994 Jun; 26(3):1172-3. PubMed ID: 8029876
    [No Abstract]   [Full Text] [Related]  

  • 37. Accelerated cardiac allograft rejection associated with administration of liver cell extract in the baboon.
    Cooper DK; Harris N; Rose AG; Novitzky D
    Transplant Proc; 1990 Aug; 22(4):1966-9. PubMed ID: 2389499
    [No Abstract]   [Full Text] [Related]  

  • 38. [Performing xenografts in infants].
    Megyeri M
    Orv Hetil; 1986 Feb; 127(6):348, 351. PubMed ID: 3513090
    [No Abstract]   [Full Text] [Related]  

  • 39. Role of ICAM-1 and LFA-1 in a cardiac xenograft rejection model.
    Miwa S; Kawasaki S; Makuuchi M; Miyasaka M; Yamazaki S; Sekiguchi M; Isobe M
    Transplant Proc; 1995 Feb; 27(1):111-2. PubMed ID: 7878820
    [No Abstract]   [Full Text] [Related]  

  • 40. Hyperacute rejection in a discordant (pig to baboon) cardiac xenograft model.
    Lexer G; Cooper DK; Rose AG; Wicomb WN; Rees J; Keraan M; Du Toit E
    J Heart Transplant; 1986; 5(6):411-8. PubMed ID: 3302173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.